Enovix Announces Proposed Public Offering of Common Stock

Rhea-AI Summary

Enovix (NASDAQ: ENVX) has announced a proposed public offering of $100.0 million of common stock shares, with an additional 30-day option for the underwriter to purchase up to $15.0 million of shares. Cantor Fitzgerald & Co. will serve as the sole book-running manager. The proceeds will be used for general corporate purposes and to support high-volume manufacturing at the company's Fab2 facility in Penang, Malaysia. The offering is made pursuant to a shelf registration statement filed with the SEC in August 2023.

Positive

• Potential to raise up to $115 million in capital through the offering
• Funds allocated to support high-volume manufacturing expansion in Malaysia

Negative

• Potential dilution of existing shareholders' value
• Additional share issuance may put downward pressure on stock price

Insights

Financial Analyst

This $100 million public offering with a potential additional $15 million option represents a significant capital raise for Enovix. The timing is strategic as the company focuses on scaling its Fab2 facility in Malaysia. However, this will lead to share dilution for existing stockholders. The sole book-runner arrangement with Cantor Fitzgerald suggests a streamlined offering process, though the final pricing and number of shares are yet to be determined.

The capital raise aligns with Enovix's expansion strategy but comes at a time when the battery sector faces market headwinds. While the funds will strengthen the balance sheet and support manufacturing scale-up, investors should monitor the offering's pricing and its impact on share value. The shelf registration approach provides flexibility but also signals potential future capital needs.

Manufacturing Operations Expert

The capital allocation towards Fab2 in Penang indicates a important phase in Enovix's manufacturing scale-up strategy. High-volume production facilities require substantial upfront investment in equipment, automation systems and operational infrastructure. The Malaysia location offers strategic advantages in terms of cost structure and proximity to the Asian supply chain ecosystem.

The focus on achieving high-volume manufacturing capabilities is essential for competing in the commercial battery market, where economies of scale significantly impact unit economics. However, the ramp-up period typically involves operational challenges and requires careful management of working capital to achieve optimal production efficiency.

FREMONT, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (NASDAQ: ENVX), a global high-performance battery company, today announced that it has commenced an underwritten public offering of $100.0 million of shares of its common stock, subject to market and other conditions. In connection with the offering, Enovix expects to grant the underwriter a 30-day option to purchase up to an additional $15.0 million of the shares of common stock offered in the public offering. There can be no assurances as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares of common stock in the offering will be sold by Enovix.

Cantor Fitzgerald & Co. is acting as sole book-running manager for the offering.

Enovix intends to use the net proceeds from this offering, together with its existing cash, cash equivalents and short-term investments, for general corporate purposes, and for working capital and capital expenses to achieve high-volume manufacturing at its high-volume production facility “Fab2” in Penang, Malaysia.

The securities described above are being offered by Enovix pursuant to a shelf registration statement on Form S-3, including a base prospectus, that was filed on August 9, 2023 and declared effective by the U.S. Securities and Exchange Commission (“SEC”) on August 18, 2023. The offering is being made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. A preliminary prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC’s website located at www.sec.gov. Copies of the preliminary prospectus supplement and the accompanying prospectus relating to the offering, when available, may also be obtained from Cantor Fitzgerald & Co., Attention: Capital Markets, 110 East 59^th Street, 6^th Floor, or by email at prospectus@cantor.com.

This press release is neither an offer to sell nor a solicitation of an offer to buy any of these securities nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to the registration or qualification thereof under the securities laws of any such state or jurisdiction.

About Enovix
Enovix is on a mission to deliver high-performance batteries that unlock the full potential of technology products. Everything from IoT, mobile, and computing devices, to the vehicle you drive, needs a better battery. Enovix partners with OEMs worldwide to usher in a new era of user experiences. Our innovative, materials-agnostic approach to building a higher performing battery without compromising safety keeps us flexible and on the cutting-edge of battery technology innovation.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, statements regarding Enovix’s anticipated public offering. The words “may,” “might,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “achieve”, “intend,” “believe,” “expect,” “estimate,” “seek,” “predict,” “future,” “project,” “potential,” “continue,” “target” and similar words or expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.

Any forward-looking statements in this press release, such as the intended offering terms, are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, uncertainties related to market conditions, the completion of the public offering on the anticipated terms or at all and Enovix’s intention to grant the underwriter an option to purchase additional shares. These and other risks and uncertainties are described in greater detail in the section entitled “Risk Factors” in Enovix’s Annual Report on Form 10-K for the year ended December 31, 2023, and its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2024, June 30, 2024 and September 30, 2024. In addition, any forward-looking statements contained in this press release represent the Enovix’s views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date. Enovix explicitly disclaims any obligation to update any forward-looking statements. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements.

For investor and media inquiries, please contact:

Enovix Corporation
Robert Lahey
Email: ir@enovix.com

FAQ

How much is Enovix (ENVX) planning to raise in its public offering?

Enovix is planning to raise $100.0 million through the public offering, with an additional option for the underwriter to purchase up to $15.0 million in shares.

What will Enovix (ENVX) use the proceeds from the offering for?

The proceeds will be used for general corporate purposes and to fund working capital and capital expenses for high-volume manufacturing at their Fab2 facility in Penang, Malaysia.

Who is the underwriter for Enovix's (ENVX) public offering?

Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering.

When was Enovix's (ENVX) shelf registration statement declared effective?

The shelf registration statement was filed on August 9, 2023, and declared effective by the SEC on August 18, 2023.